Search results
Ogunbowale scores 19, Sheldon adds 17 including 5 3s to help Wings beat Dream 85-82
The Canadian Press via Yahoo Canada Sports· 8 hours agoARLINGTON, Texas (AP) — Arike Ogunbowale scored 19 points, Jacy Sheldon hit five 3-pointers and finished with 17 points — both career highs — and the Dallas Wings beat the Atlanta Dream 85-82 Friday night.
GTA 5 Dev Talks Cancelled Single-Player DLC, Says It Was 'Really, Really Good'
Pure Xbox· 18 hours agoThere's been talk for a long time now about GTA 5's single-player DLC and plans for the character of...
Sparks beat Aces 98-93 in OT, snap 8-game skid
The Canadian Press via Yahoo Canada Sports· 5 hours agoLOS ANGELES (AP) — Dearica Hamby scored 28 points and grabbed 14 rebounds, Aari McDonald hit four 3-pointers and finished with a career-high 23 points...
Disney (DIS) Gains 8.5% YTD: How Should You Play the Stock in 2H?
Zacks via Yahoo Finance Canada· 19 hours agoDisney's (DIS) iconic brand and impressive media assets, on one hand, and competitive pressure and...
Genshin Impact 4.8 release date and new Summer event areconfirmed
VideoGamer.com· 19 hours agoThe Genshin Impact 4.8 release date has been confirmed during the special program, showing the new...
Weekend Console Download Deals for July 5: Nintendo Recollection Collection Sale
Shacknews· 22 hours agoRemember some of Nintendo's best third-party games with the eShop's latest sale.
Father of Final Fantasy has no plans to return to the series
TweakTown· 21 hours agoHironobu Sakaguchi, who created the original Final Fantasy series for Square Enix 30 years ago, says he has no plans to work on the franchsie again. After many years, the father of Final Fantasy ...
How to unlock facewear in Final Fantasy XIV | VGC
VGC· 21 hours agoNot sure how to unlock Facewear in Final Fantasy XIV? New for the Final Fantasy XIV Dawntrail expansion is a new equipment slot tailor-made for items...
Exoprimal’s seasonal content is ending, Capcom confirms | VGC
VGC· 22 hours agoCapcom has announced that the seasonal content for Exoprimal has concluded.